RTL9

gene
On this page

Also known as KIAA1318Mart9Mar9SIRH10

Summary

RTL9 (retrotransposon Gag like 9, HGNC:29245) is a protein-coding gene on chromosome Xq23, encoding Retrotransposon Gag-like protein 9 (Q8NET4).

At a glance

  • Clinical variants (ClinVar): 221 total
  • MANE Select transcript: NM_001385449

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29245
Approved symbolRTL9
Nameretrotransposon Gag like 9
LocationXq23
Locus typegene with protein product
StatusApproved
AliasesKIAA1318, Mart9, Mar9, SIRH10
Ensembl geneENSG00000243978
Ensembl biotypeprotein_coding
OMIM300965
Entrez57529

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 3 protein_coding

ENST00000465301, ENST00000520821, ENST00000540313

RefSeq mRNA: 2 — MANE Select: NM_001385449 NM_001385449, NM_020769

CCDS: CCDS14552

Canonical transcript exons

ENST00000520821 — 4 exons

ExonStartEnd
ENSE00002110296110450567110454664
ENSE00002123383110445153110445268
ENSE00003967359110455202110456334
ENSE00003967360110358848110358916

Expression profiles

Bgee: expression breadth broad, 83 present calls, max score 77.55.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0735 / max 52.7769, expressed in 14 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1972660.04669
1972650.02054
1972640.00643

Top tissues by expression

215 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibialis anteriorUBERON:000138577.55silver quality
right testisUBERON:000453474.82gold quality
left testisUBERON:000453372.19gold quality
testisUBERON:000047372.10gold quality
pancreatic ductal cellCL:000207969.01silver quality
ventricular zoneUBERON:000305366.84gold quality
ileal mucosaUBERON:000033164.56silver quality
cortical plateUBERON:000534363.02gold quality
deltoidUBERON:000147662.59gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099160.77gold quality
lower lobe of lungUBERON:000894957.87silver quality
ganglionic eminenceUBERON:000402357.08gold quality
adrenal tissueUBERON:001830357.07gold quality
hypothalamusUBERON:000189857.00gold quality
adult organismUBERON:000702357.00silver quality
epithelial cell of pancreasCL:000008355.74gold quality
cardiac muscle of right atriumUBERON:000337955.53gold quality
nucleus accumbensUBERON:000188255.31gold quality
heart left ventricleUBERON:000208454.61gold quality
right ovaryUBERON:000211854.44gold quality
left ventricle myocardiumUBERON:000656654.23gold quality
cardiac ventricleUBERON:000208254.12gold quality
kidney epitheliumUBERON:000481953.93gold quality
left ovaryUBERON:000211953.89gold quality
upper arm skinUBERON:000426353.52gold quality
oocyteCL:000002353.42gold quality
ovaryUBERON:000099252.84gold quality
prefrontal cortexUBERON:000045152.71gold quality
substantia nigraUBERON:000203851.21gold quality
heartUBERON:000094850.92gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes2.61

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

92 targeting RTL9, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-6748-5P100.0065.811057
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-3646100.0073.565283
HSA-MIR-450099.9972.722367
HSA-MIR-6759-5P99.9966.54785
HSA-LET-7A-5P99.9872.291790
HSA-LET-7B-5P99.9872.311790
HSA-LET-7C-5P99.9872.291790
HSA-LET-7E-5P99.9872.291790
HSA-LET-7F-5P99.9872.561784
HSA-LET-7G-5P99.9872.371784
HSA-LET-7I-5P99.9872.371788
HSA-MIR-98-5P99.9872.331787
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-LET-7D-5P99.9671.761632
HSA-MIR-445899.9671.641650
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-141-3P99.9472.792421
HSA-MIR-200A-3P99.9472.682420
HSA-MIR-335-3P99.9373.364958
HSA-MIR-20699.9372.501893
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-1-3P99.9372.351914
HSA-MIR-219A-5P99.9173.36735

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_reriovapENSDARG00000088975
mus_musculusRtl9ENSMUSG00000085584
rattus_norvegicusRtl9ENSRNOG00000049853
drosophila_melanogastermeshFBGN0051004
caenorhabditis_elegansWBGENE00010047
caenorhabditis_elegansWBGENE00010540
caenorhabditis_elegansWBGENE00011175

Paralogs (2): SUSD2 (ENSG00000099994), MUC4 (ENSG00000145113)

Protein

Protein identifiers

Retrotransposon Gag-like protein 9Q8NET4 (reviewed: Q8NET4)

Alternative names: Retrotransposon gag domain-containing protein 1, Tumor antigen BJ-HCC-23

All UniProt accessions (2): E5RKA1, Q8NET4

UniProt curated annotations — full annotation on UniProt →

Miscellaneous. RTL9 is one of at least 11 genes called Mar or Mart related to long terminal repeat retrotransposons. They do not correspond to functional retrotransposons, but rather to neofunctionalized retrotransposons genes.

RefSeq proteins (2): NP_001372378, NP_065820 (=MANE)

Domains & families (InterPro)

IDNameType
IPR042919RTL9Family

UniProt features (9 total): region of interest 5, compositionally biased region 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8NET4-F139.370.05

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 103 (showing top): GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP, RNGTGGGC_UNKNOWN, MYAATNNNNNNNGGC_UNKNOWN, AP1_01, FREAC2_01, HNF3ALPHA_Q6, GGGNRMNNYCAT_UNKNOWN, RORA1_01, FOXO4_01, FOXO1_01, ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP, CAGCTG_AP4_Q5, FOXD3_01, AP1_Q4_01, HEN1_01

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

718 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RTL9RTL6Q6ICC9810
RTL9RTL4Q6ZR62716
RTL9NUTM2GQ5VZR2664
RTL9RTL8CA6ZKI3606
RTL9AMMECR1Q9Y4X0600
RTL9LDOC1O95751599
RTL9TMEM164Q5U3C3578
RTL9NUGGCQ68CJ6541
RTL9MAP7D2Q96T17505
RTL9RALGPS1Q5JS13486
RTL9APOLD1Q96LR9424
RTL9RTL5Q5HYW3416
RTL9ZCCHC3Q9NUD5402
RTL9ZC3H7BQ9UGR2400
RTL9RTL1A6NKG5398

IntAct

12 interactions, top by confidence:

ABTypeScore
HSF1KPNA3psi-mi:“MI:0914”(association)0.640
CBX6IGF2BP3psi-mi:“MI:0914”(association)0.530
PRDX2PRDX3psi-mi:“MI:0914”(association)0.510
ANKRA2RTL9psi-mi:“MI:0407”(direct interaction)0.440
CIMIP4ATE1psi-mi:“MI:0914”(association)0.350
UGT1A7FGFR1psi-mi:“MI:0914”(association)0.350
UGT1A7ADAM10psi-mi:“MI:0914”(association)0.350
CD247DDX1psi-mi:“MI:0914”(association)0.350
CEP152CNOT1psi-mi:“MI:2364”(proximity)0.270
RTL9HSF1psi-mi:“MI:0915”(physical association)0.000
PRDX2RTL9psi-mi:“MI:0915”(physical association)0.000

BioGRID (12): RGAG1 (Proximity Label-MS), RGAG1 (Proximity Label-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), HSF1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS), NASP (Cross-Linking-MS (XL-MS)), RGAG1 (Affinity Capture-MS), RGAG1 (Affinity Capture-MS)

ESM2 similar proteins: A0A0U1RQI7, A0A494C071, A6QL64, A6ZXT5, A7XUY5, E2RYF6, E2RYF7, O60732, O88799, P06916, P12021, P18583, P41809, P43537, P47179, P53353, Q00130, Q02496, Q02505, Q04893, Q05049, Q12459, Q14242, Q32KG4, Q4ZJY7, Q4ZJZ0, Q54QZ8, Q5H9R4, Q5H9T9, Q5JPF3, Q5SSG8, Q5XHX6, Q60528, Q63661, Q685J3, Q6P902, Q86VQ3, Q8JZM8, Q8N307, Q8NET4

Diamond homologs: Q32KG4, Q8NET4

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

221 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance168
Likely benign14
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

716 predictions. Top by Δscore:

VariantEffectΔscore
X:110419132:GTGG:Gdonor_gain1.0000
X:110419133:TGGG:Tdonor_loss1.0000
X:110419134:GG:Gdonor_gain1.0000
X:110419135:GG:Gdonor_gain1.0000
X:110419136:G:GAdonor_loss1.0000
X:110445110:T:TAacceptor_gain1.0000
X:110419133:TGG:Tdonor_gain0.9900
X:110419134:GGG:Gdonor_gain0.9900
X:110419136:G:GGdonor_gain0.9900
X:110454599:GCCT:Gdonor_gain0.9900
X:110455194:A:AGacceptor_gain0.9900
X:110455197:CCCA:Cacceptor_loss0.9900
X:110455198:CCA:Cacceptor_loss0.9900
X:110455200:A:AGacceptor_gain0.9900
X:110455200:A:ATacceptor_loss0.9900
X:110455201:G:Aacceptor_loss0.9900
X:110455201:G:GAacceptor_gain0.9900
X:110455201:GC:Gacceptor_gain0.9900
X:110455201:GCACC:Gacceptor_gain0.9900
X:110445111:G:Aacceptor_gain0.9800
X:110454662:G:GTdonor_gain0.9800
X:110455195:C:Gacceptor_gain0.9800
X:110419131:TGTGG:Tdonor_gain0.9700
X:110419132:GTGGG:Gdonor_gain0.9700
X:110419133:TGGGT:Tdonor_gain0.9700
X:110445147:T:Gacceptor_gain0.9700
X:110454620:G:GTdonor_gain0.9700
X:110455201:GCA:Gacceptor_gain0.9700
X:110455201:GCAC:Gacceptor_gain0.9700
X:110444492:T:TAdonor_gain0.9600

AlphaMissense

558 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
X:110450645:T:CF10L0.758
X:110450647:C:AF10L0.758
X:110450647:C:GF10L0.758
X:110450828:T:CF71L0.717
X:110450830:T:AF71L0.717
X:110450830:T:GF71L0.717
X:110450699:T:CF28L0.662
X:110450701:C:AF28L0.662
X:110450701:C:GF28L0.662

dbSNP variants (sampled 300 via entrez): RS1000053110 (X:110362214 C>G,T), RS1000103740 (X:110361767 A>T), RS1000103882 (X:110423688 T>G), RS1000164254 (X:110445362 A>G), RS1000169722 (X:110421267 G>A), RS1000279452 (X:110371401 A>G), RS1000421008 (X:110360224 C>G), RS1000476139 (X:110424177 A>G), RS1000489570 (X:110445776 G>A), RS1000501363 (X:110448302 C>T), RS1000542869 (X:110395351 C>T), RS1000595426 (X:110372130 G>A,T), RS1000599925 (X:110386136 G>T), RS1000679670 (X:110363173 T>C), RS1000682331 (X:110436682 C>T)

Disease associations

OMIM: gene MIM:300965 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

21 total (human), top 21 by PubMed support.

ChemicalActions (top 5)PubMed papers
2,4,6-tribromophenoldecreases expression1
methyleugenoldecreases expression1
sodium arseniteincreases expression1
tetrabromobisphenol Adecreases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression, affects cotreatment1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
pentabrominated diphenyl ether 100increases expression1
hexabrominated diphenyl ether 153increases expression1
Sunitinibdecreases expression1
Benzo(a)pyrenedecreases expression1
Caffeineincreases phosphorylation1
Cisplatinincreases expression1
Estradiolincreases expression1
Ethyl Methanesulfonateincreases expression1
Lipopolysaccharidesincreases expression, affects response to substance, affects cotreatment1
Methyl Methanesulfonateincreases expression1
N-Nitrosopyrrolidinedecreases expression1
Valproic Aciddecreases methylation1
Aflatoxin B1decreases methylation1
Okadaic Aciddecreases expression1
S-Nitrosoglutathioneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.